Skip to content
Yog Pharma
Central nervous systemSerotonin antagonist and reuptake inhibitor

Trazodone Hydrochloride is a serotonin antagonist and reuptake inhibitor indicated for major depressive disorder. We supply it to US manufacturers of tablets.

CAS25332-39-2408.3 g/molC19H23Cl2N5O
2D structure of Trazodone Hydrochloride, shown as the active moiety without counter-ion or water of hydration.

Data from PubChem (CID 62935) and FDA’s substance registry

CAS number

25332-39-2

Molecular formula

C19H23Cl2N5O

Molecular weight

408.3g/mol

FDA UNII

IUPAC name

2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one;hydrochloride

InChIKey

OHHDIOKRWWOXMT-UHFFFAOYSA-N

Appearance
White to off-white crystalline powder.
Solubility
Sparingly soluble in water and in chloroform.

Typical description, from FDA-approved labeling and pharmacopoeial monographs. The specification sent with your quote is the controlling document for any source.

Worth settling with your inquiry

The synthesis uses alkylating intermediates, so ask how the source controls them as potential mutagenic impurities under ICH M7.

On the US market

Reference product
DesyrelNDA 018207
Approved ANDAs
15 with a marketed product
Approved forms and strengths
  • Tablet 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 300 mg
  • Oral solution 10 mg/mL

Single-ingredient products in FDA’s Drugs@FDA database, retrieved November 2026. The brand name belongs to its owner and identifies the reference product only.

Grade

USP or Ph. Eur. where a monograph exists, or your own specification.

Quantities

From development quantities for formulation work to commercial supply.

Packaging

To the manufacturer’s standard, typically fiber or HDPE drums with double polyethylene liners.

Regulatory filings

US DMF and CEP availability depends on the source. We confirm the filing status in writing with the quotation.

Documents available with a quote

  • Specification and certificate of analysis
  • Safety data sheet
  • Method of analysis
  • DMF letter of authorization, where a US DMF is filed
  • GMP certificate and inspection history of the site
  • Residual solvents and elemental impurities statements
  • Nitrosamine risk assessment
  • TSE/BSE statement

Need something else for your QA file? Email info@yogpharma.com